CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

Bicara Therapeutics Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: 617-468-4219

CIK: 0002023658
State Location: MA
State of Inc.: DE

Nasdaq:BCAX

Form: 144

Filing Date: 15 May 2026
Report Date:
Accepted: 15 May 2026 02:14 p.m.
Accession Number: 0001969223-26-000560

Act: 33
File Number: 001-42271
Film Number: 26987592

Documents

Primary Document

Accepted: 15 May 2026 02:14 p.m.

0001969223-26-000560-index-headers.html

Last Modified: 15 May 2026 02:14 p.m.

0001969223-26-000560-index.html

Last Modified: 15 May 2026 02:14 p.m.

0001969223-26-000560.txt

Last Modified: 15 May 2026 02:14 p.m.

primary_doc.xml

Last Modified: 15 May 2026 02:14 p.m.